拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 5882人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511802, encodeId=8d6f151180200, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较, objectType=article, longId=221433, objectId=288d221433d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288d221433d2, replyNumber=0, likeNumber=112, createdTime=2021-12-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288d221433d2, moduleTitle=NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=288d221433d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511801, encodeId=5b9415118015d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性, objectType=article, longId=220833, objectId=ff7e22083386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff7e22083386, replyNumber=0, likeNumber=104, createdTime=2021-11-24, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff7e22083386, moduleTitle=J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff7e22083386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511800, encodeId=b9001511800ee, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=P2X3受体拮抗剂 eliapixant对难治性慢性咳嗽的疗效和安全性, objectType=article, longId=220636, objectId=883e22063602, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=883e22063602, replyNumber=0, likeNumber=104, createdTime=2021-11-21, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=883e22063602, moduleTitle=P2X3受体拮抗剂 eliapixant对难治性慢性咳嗽的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=883e22063602)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511799, encodeId=63e31511e9965, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=CRTH2拮抗剂对鼻病毒感染引起哮喘急性加重的影响, objectType=article, longId=220079, objectId=ad582200e9da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad582200e9da, replyNumber=0, likeNumber=94, createdTime=2021-11-12, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad582200e9da, moduleTitle=CRTH2拮抗剂对鼻病毒感染引起哮喘急性加重的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad582200e9da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511798, encodeId=7e431511e988a, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Lancet子刊：AngII受体拮抗剂氯沙坦减少老年痴呆脑萎缩的安全性和有效性分析, objectType=article, longId=219894, objectId=af4c21989459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4c21989459, replyNumber=0, likeNumber=168, createdTime=2021-11-08, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4c21989459, moduleTitle=Lancet子刊：AngII受体拮抗剂氯沙坦减少老年痴呆脑萎缩的安全性和有效性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4c21989459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511797, encodeId=542e1511e97a3, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Circulation：GnRH拮抗剂和激动剂的相对心血管安全性孰高孰低？, objectType=article, longId=218896, objectId=fc4b218896c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc4b218896c7, replyNumber=0, likeNumber=89, createdTime=2021-10-21, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc4b218896c7, moduleTitle=Circulation：GnRH拮抗剂和激动剂的相对心血管安全性孰高孰低？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc4b218896c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511796, encodeId=0de51511e9631, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=CTI：生长激素释放激素拮抗剂MIA602在结节病样肉芽肿中的活性及其作用机制, objectType=article, longId=217981, objectId=809e21e981c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=809e21e981c0, replyNumber=0, likeNumber=95, createdTime=2021-10-02, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=809e21e981c0, moduleTitle=CTI：生长激素释放激素拮抗剂MIA602在结节病样肉芽肿中的活性及其作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=809e21e981c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511795, encodeId=52ce1511e9538, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Br J Clin Pharmacol：与维生素K拮抗剂相比，直接口服抗凝剂在COVID-19心脏代谢疾病门诊患者中的功效与安全性, objectType=article, longId=217655, objectId=0a9721e65504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a9721e65504, replyNumber=0, likeNumber=60, createdTime=2021-09-27, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a9721e65504, moduleTitle=Br J Clin Pharmacol：与维生素K拮抗剂相比，直接口服抗凝剂在COVID-19心脏代谢疾病门诊患者中的功效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a9721e65504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511794, encodeId=95cb1511e9420, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=2021 ESC：预防TAVR房颤患者心脏病发作或中风，艾多沙班不劣于维生素 K 拮抗剂, objectType=article, longId=216443, objectId=41892164434e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41892164434e, replyNumber=0, likeNumber=99, createdTime=2021-08-31, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41892164434e, moduleTitle=2021 ESC：预防TAVR房颤患者心脏病发作或中风，艾多沙班不劣于维生素 K 拮抗剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41892164434e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511793, encodeId=183e1511e93f7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC：抑制心肌重构，盐皮质激素受体拮抗剂对2型糖尿病患者做到了！, objectType=article, longId=215985, objectId=d21c21598511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d21c21598511, replyNumber=0, likeNumber=96, createdTime=2021-08-20, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d21c21598511, moduleTitle=JACC：抑制心肌重构，盐皮质激素受体拮抗剂对2型糖尿病患者做到了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d21c21598511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511792, encodeId=df4f1511e9288, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Heart：非维生素K拮抗剂口服抗凝剂、质子泵抑制剂与胃肠道出血的关系, objectType=article, longId=215260, objectId=a99d21526012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a99d21526012, replyNumber=0, likeNumber=88, createdTime=2021-08-05, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a99d21526012, moduleTitle=Heart：非维生素K拮抗剂口服抗凝剂、质子泵抑制剂与胃肠道出血的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a99d21526012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511791, encodeId=20881511e9122, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Allergy Asthma Clin Immunol：白三烯受体拮抗剂与选择性H1-抗组胺药治疗过敏性鼻炎：当前证据的元分析, objectType=article, longId=214560, objectId=d7032145600f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7032145600f, replyNumber=0, likeNumber=54, createdTime=2021-07-23, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7032145600f, moduleTitle=Allergy Asthma Clin Immunol：白三烯受体拮抗剂与选择性H1-抗组胺药治疗过敏性鼻炎：当前证据的元分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7032145600f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511790, encodeId=ccc31511e9072, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAMA：在COVID-19住院患者中，IL-6拮抗剂与28天全因死亡率相关?, objectType=article, longId=214180, objectId=a896214180aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a896214180aa, replyNumber=0, likeNumber=137, createdTime=2021-07-15, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a896214180aa, moduleTitle=JAMA：在COVID-19住院患者中，IL-6拮抗剂与28天全因死亡率相关?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a896214180aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511789, encodeId=e7ed1511e8968, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Am J Gastr: 质子泵抑制剂与组胺 2 受体拮抗剂对胃癌的发生风险均没有特殊影响, objectType=article, longId=212334, objectId=8d072123346c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d072123346c, replyNumber=0, likeNumber=169, createdTime=2021-06-07, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d072123346c, moduleTitle=Am J Gastr: 质子泵抑制剂与组胺 2 受体拮抗剂对胃癌的发生风险均没有特殊影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d072123346c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511788, encodeId=a0f91511e8802, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Circulation：IL-6R拮抗剂托珠单抗可有效减轻心脏骤停后综合征患者的全身炎症反应, objectType=article, longId=211450, objectId=95f6211450ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95f6211450ec, replyNumber=0, likeNumber=91, createdTime=2021-05-19, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95f6211450ec, moduleTitle=Circulation：IL-6R拮抗剂托珠单抗可有效减轻心脏骤停后综合征患者的全身炎症反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95f6211450ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511787, encodeId=ec641511e873e, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JCEM：盐皮质激素受体拮抗剂对原发性醛固酮增多症患者醛固酮与肾素比值的影响, objectType=article, longId=210935, objectId=cad621093570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cad621093570, replyNumber=0, likeNumber=87, createdTime=2021-05-09, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cad621093570, moduleTitle=JCEM：盐皮质激素受体拮抗剂对原发性醛固酮增多症患者醛固酮与肾素比值的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cad621093570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511786, encodeId=72301511e86a4, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Ann Rheum Dis：使用维生素K拮抗剂与骨关节炎发病和进展的风险升高相关, objectType=article, longId=210186, objectId=c5bf210186ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5bf210186ae, replyNumber=0, likeNumber=102, createdTime=2021-04-21, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5bf210186ae, moduleTitle=Ann Rheum Dis：使用维生素K拮抗剂与骨关节炎发病和进展的风险升高相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5bf210186ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511785, encodeId=42ab1511e85cb, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Expert Rev Clin Pharmacol：与非维生素K拮抗剂口服抗凝剂的药物相互作用在老年患者中风预防中的新近进展, objectType=article, longId=209245, objectId=cbb02092451b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbb02092451b, replyNumber=0, likeNumber=50, createdTime=2021-04-01, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbb02092451b, moduleTitle=Expert Rev Clin Pharmacol：与非维生素K拮抗剂口服抗凝剂的药物相互作用在老年患者中风预防中的新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbb02092451b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511784, encodeId=92ab1511e8470, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Br J Cancer：H2拮抗剂雷尼替丁在紫杉醇治疗期间的附加价值, objectType=article, longId=209019, objectId=0a9820901930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a9820901930, replyNumber=0, likeNumber=114, createdTime=2021-03-27, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a9820901930, moduleTitle=Br J Cancer：H2拮抗剂雷尼替丁在紫杉醇治疗期间的附加价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a9820901930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511783, encodeId=03881511e8398, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC：美英法德跨国研究观察到盐皮质激素受体拮抗剂和恩帕格列净在心衰中的作用, objectType=article, longId=208709, objectId=4dfc208e0936, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dfc208e0936, replyNumber=0, likeNumber=91, createdTime=2021-03-21, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dfc208e0936, moduleTitle=JACC：美英法德跨国研究观察到盐皮质激素受体拮抗剂和恩帕格列净在心衰中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dfc208e0936)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

NEJM：依度沙班对比维生素K拮抗剂治疗TAVR后房颤的疗效比较

2021-12-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

J Clin Oncol：神经激肽-1受体拮抗剂fosnetupitant (FosNTP)对比fosaprepitant (FosAPR)预防高致吐性化疗引起的恶心和呕吐的有效性和安全性

2021-11-24

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

P2X3受体拮抗剂 eliapixant对难治性慢性咳嗽的疗效和安全性

2021-11-21

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

CRTH2拮抗剂对鼻病毒感染引起哮喘急性加重的影响

2021-11-12

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Lancet子刊：AngII受体拮抗剂氯沙坦减少老年痴呆脑萎缩的安全性和有效性分析

2021-11-08

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Circulation：GnRH拮抗剂和激动剂的相对心血管安全性孰高孰低？

2021-10-21

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

CTI：生长激素释放激素拮抗剂MIA602在结节病样肉芽肿中的活性及其作用机制

2021-10-02

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Br J Clin Pharmacol：与维生素K拮抗剂相比，直接口服抗凝剂在COVID-19心脏代谢疾病门诊患者中的功效与安全性

2021-09-27

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

2021 ESC：预防TAVR房颤患者心脏病发作或中风，艾多沙班不劣于维生素 K 拮抗剂

2021-08-31

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC：抑制心肌重构，盐皮质激素受体拮抗剂对2型糖尿病患者做到了！

2021-08-20

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Heart：非维生素K拮抗剂口服抗凝剂、质子泵抑制剂与胃肠道出血的关系

2021-08-05

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Allergy Asthma Clin Immunol：白三烯受体拮抗剂与选择性H1-抗组胺药治疗过敏性鼻炎：当前证据的元分析

2021-07-23

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAMA：在COVID-19住院患者中，IL-6拮抗剂与28天全因死亡率相关?

2021-07-15

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Am J Gastr: 质子泵抑制剂与组胺 2 受体拮抗剂对胃癌的发生风险均没有特殊影响

2021-06-07

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Circulation：IL-6R拮抗剂托珠单抗可有效减轻心脏骤停后综合征患者的全身炎症反应

2021-05-19

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JCEM：盐皮质激素受体拮抗剂对原发性醛固酮增多症患者醛固酮与肾素比值的影响

2021-05-09

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Ann Rheum Dis：使用维生素K拮抗剂与骨关节炎发病和进展的风险升高相关

2021-04-21

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Expert Rev Clin Pharmacol：与非维生素K拮抗剂口服抗凝剂的药物相互作用在老年患者中风预防中的新近进展

2021-04-01

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Br J Cancer：H2拮抗剂雷尼替丁在紫杉醇治疗期间的附加价值

2021-03-27

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC：美英法德跨国研究观察到盐皮质激素受体拮抗剂和恩帕格列净在心衰中的作用

2021-03-21

科室
- - 订阅+
  - 更多科室
工具
服务